Sep 9, 2021 | News, Regulatory
The US FDA (Food and Drug Administration) has granted Ohio-based pharmaceutical company Soin Therapeutics orphan drug status for low dose naltrexone (LDN) for the treatment of complex regional pain syndrome (CRPS). Complex Regional Pain Syndrome is characterized by...
Sep 7, 2021 | Medical Translation
A new study has found that approximately 2% of patients with inflammatory bowel diseases (IBD) will develop primary sclerosing cholangitis (PSC), with more men developing the condition compared to women. The analysis, published in Gastroenterology, also states that...
Sep 3, 2021 | News, Regulatory
A UK study has shown that the risk of developing long COVID, as well as severe illness caused by COVID-19, is greatly reduced in a person who is fully vaccinated. Published by the Lancet Infectious Diseases Journal, the study indicates that those who have received...
Sep 3, 2021 | News, Regulatory
The US FDA (Food and Drug Administration) has asked Eli Lilly & Co, Pfizer, and AbbVie, to inform consumers about potential risks relating to their high-profile Janus kinase (JAK) inhibitor medications. The FDA has ordered label warnings that list a heightened...
Sep 2, 2021 | News, Regulatory
Dubbed a global health concern, The WHO (World Health Organization) has projected that the number of people living with dementia will increase to 78 million by the year 2030 and will cost the global economy $1.3 trillion p/a. Currently, there are over 55 million...
